RxSight (RXST) Operating Leases (2020 - 2026)
RxSight (RXST) posted Operating Leases of $9.3 million for Q1 2026, down 5.63% on a QoQ basis from $9.9 million in Q4 2025, and down 15.15% year-over-year from $11.0 million in Q1 2025.
RxSight (RXST) Operating Leases (2020 - 2026) Analysis & Trends
RxSight's Operating Leases history runs 7 years deep, the most recent figure standing at $9.3 million for Q1 2026.
- Quarterly Operating Leases fell 15.15% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (down 15.15% YoY) and the FY2025 annual result came in at $9.9 million, down 12.75% from the prior year.
- Operating Leases was $9.3 million for Q1 2026 at RxSight, down from $9.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $11.3 million in Q4 2024 and bottomed at $908000.0 in Q1 2024.
- A 5-year average of $6.2 million and a median of $3.9 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases plunged 61.16% — and 2025, when it soared 1110.02%.
- RxSight's Operating Leases stood at $2.9 million in 2022, then plunged by 57.6% to $1.2 million in 2023, then soared by 834.93% to $11.3 million in 2024, then slipped by 12.75% to $9.9 million in 2025, then decreased by 5.63% to $9.3 million in 2026.
- Business Quant data shows RXST's Operating Leases at $9.3 million in Q1 2026, $9.9 million in Q4 2025, and $10.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.32 Mn |
| Dec 31, 2025 | 9.88 Mn |
| Sep 30, 2025 | 10.27 Mn |
| Jun 30, 2025 | 10.61 Mn |
| Mar 31, 2025 | 10.99 Mn |
| Dec 31, 2024 | 11.32 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 10.67 Mn |
| Mar 31, 2024 | 908,000.00 |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 3.35 Mn |
| Jun 30, 2022 | 3.85 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Dec 31, 2021 | 3.64 Mn |
| Sep 30, 2021 | 4.03 Mn |
| Jun 30, 2021 | 4.37 Mn |